ArticleJBMR plus2022

The Real-World Effect of 12 Months of Romosozumab Treatment on Patients With Osteoporosis With a High Risk of Fracture and Factors Predicting the Rate of Bone Mass Increase: A Multicenter Retrospective Study.

Hiroyuki Inose et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.